Location History:
- Gottingen, DE (2008)
- Goettingen, DE (2011 - 2015)
- Halle/Saale, DE (2016)
- Göttingen, DE (2007 - 2021)
Company Filing History:
3 out of 13 
3 out of 1,537 
1 out of 1 Years Active: 2007-2021
Title: Arnd Steuernagel: A Visionary Inventor from Goettingen
Introduction
Arnd Steuernagel is a notable inventor based in Goettingen, Germany, recognized for his significant contributions to the field of biotechnology. With a total of nine patents to his name, Steuernagel has focused his research primarily on innovative methods related to viruses and binding proteins, showcasing his dedication to advancing medical science.
Latest Patents
Among his latest innovations are two pivotal patents. The first one pertains to the retargeting of viruses or virus-like particles (VLPs). This invention details a method for producing polyomavirus or polyomavirus-derived VLPs that carry specific targeting molecules on their surface. This technology has potential applications in medicine, allowing for targeted therapy in various diseases. The second patent involves dimeric binding proteins based on modified ubiquitins. These novel proteins, characterized by amino acid substitutions and insertions, provide high-affinity binding capabilities. The potential applications of these proteins extend to medical diagnostics and treatment methods.
Career Highlights
Throughout his career, Arnd Steuernagel has been associated with prominent companies, including Scil Proteins GmbH and Boehringer Ingelheim International GmbH. His work within these organizations has fostered collaboration and development in biopharmaceuticals, culminating in his impressive patent portfolio.
Collaborations
Steuernagel has collaborated with esteemed colleagues such as Karsten Eulenberg and Thomas Ciossek. Their combined expertise has undoubtedly contributed to the successful development of innovative concepts and transformative technologies within the biotechnology field.
Conclusion
Arnd Steuernagel stands out as an influential inventor whose work continues to make waves in the biotechnological landscape. His contributions through patents not only advance science but also hold promise for future medical applications, highlighting the importance of innovation in improving health outcomes.